Whitehawk Therapeutics Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Whitehawk Therapeutics Inc.
Former names: Aadi Bioscience, Inc. Aerpio Pharmaceuticals, Inc. Zeta Acquisition Corp II
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Morristown
Headquarters state / province: New Jersey
Headquarters country: United States
Fiscal year end: December
Ticker symbol: WHWK
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001422142
EIN: 61-1547850

Board of directors

Follow this board

Anupam Dalal · Director
Since 2023
Baiteng Zhao · Director
Since 2024
Behzad Aghazadeh · Director
Since 2023
Brendan Delaney · Director · See remarks
Since 2023
Caley Castelein · Director
Since 2023
David James Lennon · Director · CHIEF EXECUTIVE OFFICER
Since 2023
Emma Reeve · Director
Since 2023
Karin M. Hehenberger · Director
Since 2023
Mohammad Hirmand · Director
Since 2023
Neil Desai · Director · EXECUTIVE CHAIRMAN
Since 2023
Richard E. Maroun · Director
Since 2023
Vijay K. Iyengar · Director
Since 2026

Chief executives

David James Lennon · Chief Executive Officer

Since October 2023

0 CEO score

Weak · grade F

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 20% of the scoring weight is on file.

Revenue growth 20%: 0

20% of the scoring weight is on file. Figures cover December 2022 – December 2025.

Director election results

Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 4 other boards. 4 are in the same sector.

Shared director Other board Same sector

BeyondSpring Inc. Same sector
via Brendan Delaney
Editas Medicine Inc. Same sector
via Emma Reeve
PTC Therapeutics Inc. Same sector
via Emma Reeve
Scribe Therapeutics Inc. Same sector
via Behzad Aghazadeh

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $2,584,564; 14 sales by 3 insiders

Date	Insider	Transaction	Shares	Price	Value
May 14, 2026	Margaret Dugan Officer (Chief Medical Officer)	Grant or award	+19,132	$3.92	$74,997
May 14, 2026	BALL BRYAN Officer (See remarks)	Grant or award	+51,020	$3.92	$199,998
May 14, 2026	Giacobello Scott M. Officer (CHIEF FINANCIAL OFFICER)	Grant or award	+38,265	$3.92	$149,999
May 14, 2026	David James Lennon Director, Officer (CHIEF EXECUTIVE OFFICER)	Grant or award	+51,021	$3.92	$200,002
May 14, 2026	Caley Castelein Director	Grant or award	+255,102	$3.92	$1,000,000
May 14, 2026	Anupam Dalal Director	Grant or award	+1,275,510	$3.92	$4,999,999
Apr 16, 2026	Giacobello Scott M. Officer (CHIEF FINANCIAL OFFICER)	Open-market sale	−141,600	$4.13	$584,808
Apr 15, 2026	Giacobello Scott M. Officer (CHIEF FINANCIAL OFFICER)	Open-market sale	−77,000	$3.86	$297,220
Apr 14, 2026	BALL BRYAN Officer (See remarks)	Open-market sale	−92,460	$3.64	$336,554
Apr 13, 2026	BALL BRYAN Officer (See remarks)	Open-market sale	−26,389	$3.46	$91,306
Apr 10, 2026	BALL BRYAN Officer (See remarks)	Open-market sale	−6,596	$3.43	$22,624
Apr 9, 2026	BALL BRYAN Officer (See remarks)	Open-market sale	−50,000	$3.57	$178,500
Apr 9, 2026	David James Lennon Director, Officer (CHIEF EXECUTIVE OFFICER)	Open-market sale	−14,500	$3.38	$49,010
Apr 8, 2026	David James Lennon Director, Officer (CHIEF EXECUTIVE OFFICER)	Open-market sale	−63,945	$3.40	$217,413
Apr 7, 2026	David James Lennon Director, Officer (CHIEF EXECUTIVE OFFICER)	Open-market sale	−94,087	$3.43	$322,718

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Whitehawk Therapeutics Inc.

Who is the CEO of Whitehawk Therapeutics Inc.?

David James Lennon has been Whitehawk Therapeutics Inc.'s Chief Executive Officer since October 2023.

How many directors are on Whitehawk Therapeutics Inc.'s board?

Whitehawk Therapeutics Inc.'s board has 12 directors: Anupam Dalal, Baiteng Zhao, Behzad Aghazadeh, Brendan Delaney, Caley Castelein, David James Lennon, Emma Reeve, Karin M. Hehenberger, Mohammad Hirmand, Neil Desai and 2 others.

Are Whitehawk Therapeutics Inc. insiders buying or selling shares?

Over the last 12 months, Whitehawk Therapeutics Inc. insiders made no open-market purchases and sold $2.6 million of shares in 14 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Whitehawk Therapeutics Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="whitehawk-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.